Merck Insomnia Drug Safe Only in Low Doses

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
Real-Time Tracking for Jets Near, Rockwell Collins Says
40:37 - March 3 -- Kelly Ortberg, chief executive officer of Rockwell Collins Inc., talks about the market outlook for the aerospace supplier, the impact of the U.S. dollar, euro and cheaper oil on business, and plans to unveil technology that would enable airlines to continuously and inexpensively track jetliners in real time. Ortberg also discusses connectivity for airline passengers and crew members. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line."
  • Live From Beijing...It's Saturday Night!
  • Vote of Confidence for Lumber Liquidators
  • House Passes DHS Funds